4-AminopyridineAminopyridinesSafetyPotassium Channel BlockersTetraethylammoniumTetraethylammonium CompoundsPotassium ChannelsSafety ManagementMembrane PotentialsPotassium Channels, Voltage-GatedPatient SafetyPotassiumCharybdotoxinAction PotentialsTreatment OutcomePatch-Clamp TechniquesElectrophysiologyDelayed Rectifier Potassium ChannelsKv1.5 Potassium ChannelElapid VenomsBarium CompoundsDose-Response Relationship, DrugNeuromuscular Depolarizing AgentsApaminBariumTetrodotoxinElectric ConductivityCalciumFood SafetyDouble-Blind MethodTime FactorsCesiumGlyburideEquipment SafetyRats, Sprague-DawleyQuinidineGuinea PigsPotassium Channels, Calcium-ActivatedElectric StimulationRats, WistarKv1.4 Potassium ChannelScorpion VenomsIon ChannelsShaw Potassium ChannelsNeuronsQuinineIon Channel GatingCalcium Channel BlockersHippocampusConsumer Product SafetyKv1.1 Potassium ChannelDrug Therapy, CombinationDrug Administration ScheduleSynaptic TransmissionShab Potassium ChannelsKv1.2 Potassium ChannelEndothelium-Dependent Relaxing FactorsConvulsantsMuscle, Smooth, VascularQuinoxalinesPyridostigmine BromideMicroelectrodesCells, CulturedCarbohydrate SequenceAdministration, OralDogsPyridinesTubocurarineAcetylcholineVasodilationShaker Superfamily of Potassium ChannelsMedical ErrorsShal Potassium ChannelsMuscle RelaxationEvoked PotentialsProcaineCromakalimDrug-Related Side Effects and Adverse ReactionsCadmiumVasodilator AgentsKineticsNeuromuscular JunctionPulmonary Stretch ReceptorsProspective StudiesLarge-Conductance Calcium-Activated Potassium ChannelsPyramidal CellsEpilepsyPotassium Channels, Tandem Pore DomainSeizuresPinacidilAnti-Arrhythmia AgentsPulmonary ArteryRabbitsHeartPolymyxinsCalcium ChannelsVerapamilDrug CombinationsHeart VentriclesPotassium Chloride